Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and subacute liver injury after partial hepatectomy at high altitude
ChiCTR2400079922Phase 4Recruiting
- Sponsor
- Qinghai Provincial People's Hospital
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine in hepatic disease (2 arms), sponsored by Qinghai Provincial People's Hospital. Primary endpoint: Liver function. Started Jan 2024; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
hepatic disease
Beyond the preview
Go deeper on ChiCTR2400079922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400079922.